NO3006027T3 - - Google Patents

Info

Publication number
NO3006027T3
NO3006027T3 NO15187946A NO15187946A NO3006027T3 NO 3006027 T3 NO3006027 T3 NO 3006027T3 NO 15187946 A NO15187946 A NO 15187946A NO 15187946 A NO15187946 A NO 15187946A NO 3006027 T3 NO3006027 T3 NO 3006027T3
Authority
NO
Norway
Application number
NO15187946A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3006027T3 publication Critical patent/NO3006027T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO15187946A 2014-10-08 2015-10-01 NO3006027T3 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITTO20140806 2014-10-08

Publications (1)

Publication Number Publication Date
NO3006027T3 true NO3006027T3 (cg-RX-API-DMAC10.html) 2018-04-14

Family

ID=52101507

Family Applications (1)

Application Number Title Priority Date Filing Date
NO15187946A NO3006027T3 (cg-RX-API-DMAC10.html) 2014-10-08 2015-10-01

Country Status (14)

Country Link
US (1) US9707198B2 (cg-RX-API-DMAC10.html)
EP (1) EP3006027B1 (cg-RX-API-DMAC10.html)
JP (1) JP6447716B2 (cg-RX-API-DMAC10.html)
KR (1) KR102077374B1 (cg-RX-API-DMAC10.html)
AU (1) AU2015329581B2 (cg-RX-API-DMAC10.html)
CA (1) CA2958033C (cg-RX-API-DMAC10.html)
DK (1) DK3006027T3 (cg-RX-API-DMAC10.html)
ES (1) ES2651903T3 (cg-RX-API-DMAC10.html)
HU (1) HUE035699T2 (cg-RX-API-DMAC10.html)
NO (1) NO3006027T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ728962A (cg-RX-API-DMAC10.html)
PL (1) PL3006027T3 (cg-RX-API-DMAC10.html)
RU (1) RU2668373C1 (cg-RX-API-DMAC10.html)
WO (1) WO2016055948A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3294279T3 (pl) * 2015-05-14 2020-06-29 Professional Dietetics International S.R.L. Kompozycje zawierające aminokwasy do zastosowania w leczeniu zapalenia błony śluzowej u pacjentów cierpiących na neoplazję poddawanych radioterapii i/lub chemioterapii
IT201700087376A1 (it) * 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780475A (en) * 1986-02-03 1988-10-25 Cerra Frank B Preparation for the prevention of catabolism
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
IT1320783B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al miglioramento delleprestazioni muscolari.
US20030060421A1 (en) * 2001-07-19 2003-03-27 Neuron Therapeutics, Inc. Kits and compositions supporting intracranial perfusions
EP2275084A1 (en) * 2009-07-15 2011-01-19 Unilever PLC Oral care composition
RU2012105901A (ru) * 2009-07-20 2013-08-27 Нестек С.А. Способы снижения потери функционального состояния
PH12013501571A1 (en) * 2011-03-01 2013-09-30 Nestec Sa Extensional viscosity to promote safe swallowing of food boluses
WO2012133198A1 (ja) * 2011-03-25 2012-10-04 イーエヌ大塚製薬株式会社 炎症性疾患用栄養組成物
JP2012214451A (ja) * 2011-03-25 2012-11-08 En Otsuka Pharmaceutical Co Ltd 炎症性疾患用アミノ酸組成物
JP5837315B2 (ja) * 2011-03-25 2015-12-24 イーエヌ大塚製薬株式会社 炎症性疾患用栄養組成物
WO2012142678A1 (en) * 2011-04-21 2012-10-26 Fit-Bioceuticals Limited Weight loss composition
RU2526826C2 (ru) * 2012-10-24 2014-08-27 Николай Владимирович Соловьёв Композиция для парентерального введения, способ получения и применение композиции

Also Published As

Publication number Publication date
WO2016055948A1 (en) 2016-04-14
AU2015329581B2 (en) 2019-02-07
AU2015329581A1 (en) 2017-03-02
RU2668373C1 (ru) 2018-09-28
ES2651903T3 (es) 2018-01-30
KR102077374B1 (ko) 2020-02-13
CA2958033A1 (en) 2016-04-14
KR20170057308A (ko) 2017-05-24
JP2017530103A (ja) 2017-10-12
JP6447716B2 (ja) 2019-01-09
NZ728962A (en) 2019-05-31
CA2958033C (en) 2019-07-16
EP3006027A1 (en) 2016-04-13
US9707198B2 (en) 2017-07-18
US20160101078A1 (en) 2016-04-14
EP3006027B1 (en) 2017-11-15
DK3006027T3 (en) 2017-12-18
PL3006027T3 (pl) 2018-02-28
HUE035699T2 (en) 2018-05-28

Similar Documents

Publication Publication Date Title
BR112016013482A2 (cg-RX-API-DMAC10.html)
BR112016015519A2 (cg-RX-API-DMAC10.html)
BR112016015890A2 (cg-RX-API-DMAC10.html)
BR112016003131A2 (cg-RX-API-DMAC10.html)
BR112016016490A2 (cg-RX-API-DMAC10.html)
BR112016016708A2 (cg-RX-API-DMAC10.html)
BR112016016546A2 (cg-RX-API-DMAC10.html)
BR112016014949A2 (cg-RX-API-DMAC10.html)
BR112016016595A2 (cg-RX-API-DMAC10.html)
BR112016016421A2 (cg-RX-API-DMAC10.html)
BR112016016446A2 (cg-RX-API-DMAC10.html)
BR112016016106A2 (cg-RX-API-DMAC10.html)
BR112016012568A2 (cg-RX-API-DMAC10.html)
BR112016016558A2 (cg-RX-API-DMAC10.html)
BR112016015938A2 (cg-RX-API-DMAC10.html)
BR112016015915A2 (cg-RX-API-DMAC10.html)
BR112016015243A2 (cg-RX-API-DMAC10.html)
BR112016015542A2 (cg-RX-API-DMAC10.html)
BR112016016389A2 (cg-RX-API-DMAC10.html)
BR112016016468A2 (cg-RX-API-DMAC10.html)
BR112016016518A2 (cg-RX-API-DMAC10.html)
BR112016016657A2 (cg-RX-API-DMAC10.html)
BR112016016459A2 (cg-RX-API-DMAC10.html)
BR112016003522A2 (cg-RX-API-DMAC10.html)
BR112016015133A2 (cg-RX-API-DMAC10.html)